Tags

Type your tag names separated by a space and hit enter

SARS-CoV-2: Virology, epidemiology, immunology and vaccine development.
Biologicals. 2020 Jul; 66:35-40.B

Abstract

This first International Alliance for Biological Standardization Covid-19 webinar brought together a broad range of international stakeholders, including academia, regulators, funders and industry, with a considerable delegation from low- and middle-income countries, to discuss the virology, epidemiology and immunology of, and the vaccine development for SARS-CoV-2.

Authors+Show Affiliations

P95 Epidemiology & Pharmacovigilance, Leuven, Belgium. Electronic address: marc.baay@p-95.com.University Claude Bernard Lyon, VirPath Research Laboratory, Lyon, France. Electronic address: bruno.lina@univ-lyon1.fr.Department of Global Health, Emerging Diseases Epidemiology Unit, Institut Pasteur, Paris, France. Electronic address: arnaud.fontanet@pasteur.fr.Institute for Medical Immunology, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: arnaud.marchant@ulb.be.Vaccine R&D, CEPI Vaccines, London, UK. Electronic address: melanie.saville@cepi.net.International Alliance for Biological Standardization - IABS, Geneva, Switzerland. Electronic address: philippe.sabot@iabs.org.ADVAC, University of Geneva, Geneva, Switzerland. Electronic address: Philippe.Duclos@unige.ch.International Alliance for Biological Standardization - IABS, Geneva, Switzerland. Electronic address: joris.vandeputte@iabs.org.International Alliance for Biological Standardization - IABS, Geneva, Switzerland. Electronic address: Pieter.neels@vaccine-advice.be.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32600951

Citation

Baay, Marc, et al. "SARS-CoV-2: Virology, Epidemiology, Immunology and Vaccine Development." Biologicals : Journal of the International Association of Biological Standardization, vol. 66, 2020, pp. 35-40.
Baay M, Lina B, Fontanet A, et al. SARS-CoV-2: Virology, epidemiology, immunology and vaccine development. Biologicals. 2020;66:35-40.
Baay, M., Lina, B., Fontanet, A., Marchant, A., Saville, M., Sabot, P., Duclos, P., Vandeputte, J., & Neels, P. (2020). SARS-CoV-2: Virology, epidemiology, immunology and vaccine development. Biologicals : Journal of the International Association of Biological Standardization, 66, 35-40. https://doi.org/10.1016/j.biologicals.2020.06.005
Baay M, et al. SARS-CoV-2: Virology, Epidemiology, Immunology and Vaccine Development. Biologicals. 2020;66:35-40. PubMed PMID: 32600951.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - SARS-CoV-2: Virology, epidemiology, immunology and vaccine development. AU - Baay,Marc, AU - Lina,Bruno, AU - Fontanet,Arnaud, AU - Marchant,Arnaud, AU - Saville,Melanie, AU - Sabot,Philippe, AU - Duclos,Philippe, AU - Vandeputte,Joris, AU - Neels,Pieter, Y1 - 2020/06/23/ PY - 2020/06/17/received PY - 2020/06/19/accepted PY - 2020/7/1/pubmed PY - 2020/8/7/medline PY - 2020/7/1/entrez KW - Epidemiology KW - Immunology KW - SARS-CoV-2 KW - Vaccine development KW - Virology SP - 35 EP - 40 JF - Biologicals : journal of the International Association of Biological Standardization JO - Biologicals VL - 66 N2 - This first International Alliance for Biological Standardization Covid-19 webinar brought together a broad range of international stakeholders, including academia, regulators, funders and industry, with a considerable delegation from low- and middle-income countries, to discuss the virology, epidemiology and immunology of, and the vaccine development for SARS-CoV-2. SN - 1095-8320 UR - https://www.unboundmedicine.com/medline/citation/32600951/SARS_CoV_2:_Virology_epidemiology_immunology_and_vaccine_development_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1045-1056(20)30066-X DB - PRIME DP - Unbound Medicine ER -